U.S. stocks lost momentum at the close on Friday, posting weekly losses as Wall Street digested lower-than-expected inflation data to guide interest rates.
The S&P 500 (^GSPC) was slightly above flatline and the Dow Jones Industrial Average (^DJI) closed up 0.1%. The tech-heavy Nasdaq Composite Index (^IXIC) fell 0.2%.
The Dow and S&P 500 both fell more than 1%, and the Nasdaq fell more than 2% during the same period.
Data released by the U.S. Bureau of Labor Statistics on Friday showed that inflation cooled more than expected in January. The consumer price index showed that consumer prices in January increased by 0.2% month-on-month and 2.4% year-on-year.
The report could affect expectations for already complex Fed policy. Traders have renewed bets on a rate cut in June, with most expecting a quarter-percentage point cut that month. Most are still betting on two rate cuts by the end of 2026, but a larger proportion of traders are now betting on more rate cuts.
The moves follow a day of heavy selling as concerns about AI disruption spread into sectors such as real estate, logistics and transportation – “old economy” names previously seen as safe alternatives to AI-related stocks. Technology stocks were hammered, with all seven of the “Big Seven” mega-cap stocks ending lower. The sell-off led to sharp weekly losses for the Dow, S&P 500 and Nasdaq.
Investors are also paying close attention to the latest earnings reports to prevent the next “shoot first, ask questions later” AI scare. Shares of Applied Materials (AMAT) surged as the chip tool maker’s upbeat outlook reflected strong demand for artificial intelligence. But Pinterest (PINS) shares tumbled after a revenue shortfall and analysts worried that its Discovery platform faces artificial intelligence risks.
Elsewhere on the earnings front, Rivian (RIVN) surged more than 25% late Thursday after its fourth-quarter earnings beat estimates. The electric carmaker said it expects deliveries of its R2 midsize model before summer. Moderna (MRNA) shares soared 10% after the company beat quarterly revenue estimates on strong sales of its Covid vaccine.
live 17 updates